MCLE
Medicale Corp.0.1190
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
704.48KP/E (TTM)
-Basic EPS (TTM)
-0.01Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
Medicale Corp narrowed its Q3 FY2025 net loss to $5,528 from $10,461 a year earlier, a 47% drop, while operating expenses fell 62% to $3,575 on lower audit and filing fees. For the nine months ended June 30, 2025, the net loss improved 26% to $30,483 versus $41,332 last year, with operating cash use easing to $16,551 from $68,076, offset by $16,392 in new convertible notes. Cash hit zero, depleted by operations, leaving a $29,439 working capital deficit against $99,977 in long-term convertible debt at 8% interest, maturing 2029-2031. No revenue yet as the company preps for dietary supplement distribution. Losses match across operating and net lines, with EPS at $(0.00) for the quarter on 5,920,000 shares. Disclosure controls remain ineffective due to sole officer oversight. Convertible notes loom as a dilution risk.
10-Q
Q2 FY2025 results
Medicale Corp narrowed its Q2 FY2025 net loss to $8,275 from $11,564 a year earlier, a 28% improvement, while YTD losses eased 19% to $24,955, driven by 41% lower general and administrative expenses like audit and filing fees. Operating losses shrank accordingly, with no revenue yet as the company builds its dietary supplements consulting business. Cash depleted to zero after $14,530 in operating outflows, offset by $14,371 from new convertible notes at 8% interest maturing through 2030, pushing total debt to $97,956 and widening the working capital deficit to $25,932. EPS holds at $(0.00) basic and diluted across 5,920,000 shares, consistent with anti-dilutive effects from notes. No capex means free cash flow not disclosed in the 10-Q. Losses remain small. Yet regulatory hurdles could stall market entry.
10-Q
Q1 FY2025 results
Medicale Corp narrowed its net loss to $12,680 for Q1 FY2025 ended December 31, 2024, down 34% y/y from $19,307, as general and administrative expenses dropped 43% to $10,995, mainly from lower audit, transfer agent, and filing fees. Operating loss improved to $10,995 from $19,307 y/y, while interest expense of $1,685 widened the gap to net loss by 15%, attributable to convertible notes. Cash held steady at $159, with $10,000 in operating cash burn fully funded by new convertible note proceeds, leaving total debt at $93,585 (8% rate, convertible at $0.01/share, maturities through 2030) and a $18,028 working capital deficit. No revenue yet; operations remain pre-launch. Disclosure controls falter due to sole officer handling all duties.
10-K
FY2024 results
Medicale Corp, a development-stage company, posted a net loss of $58,213 for FY2024 ended September 30, up from $37,138 in FY2023, driven by higher operational expenses of $54,707 versus $37,593 the prior year, with no revenue generated in either period. Quarterly breakdowns remain undisclosed, but annual cash burn intensified, with operating activities consuming $83,585 compared to $25,739 last year, fully offset by financing inflows. Total assets held steady at $159, underscoring minimal operations. No dividends or buybacks occurred. The company lacks formal data backups, risking loss of critical financial records.
8-K
Auditor change announced
Medicale Corp. dismissed GreenGrowth CPAs as its independent auditor on December 31, 2024, effective immediately, after clean audit reports for fiscal 2023 that noted going concern doubts. The board simultaneously appointed Victor Mokuolu, CPA PLLC to fill the role for the fiscal year ending September 30, 2024, with no prior consultations or issues. No disagreements or reportable events marred the transition. Smooth switch.
BIOE
Bio Essence Corp.
0.05+0.00
CHEF
The Chefs' Warehouse, Inc.
63.33+0.04
GEGP
Gold Entertainment Group, Inc.
0.00+0.00
HAIAF
Healthcare AI Acquisition Corp.
12.74+0.00
IVFH
Innovative Food Holdings, Inc.
0.32-0.02
MAJI
Marijuana Inc.
0.05-0.02
MLEC
Moolec Science SA
0.33-0.04
MTEX
Mannatech, Incorporated
8.33+0.01
SNYR
Synergy CHC Corp.
1.85-0.11
USFD
US Foods Holding Corp.
76.48+0.28